ID GLRX2_MOUSE Reviewed; 156 AA. AC Q923X4; Q9DAG8; Q9JHY6; DT 30-AUG-2005, integrated into UniProtKB/Swiss-Prot. DT 01-DEC-2001, sequence version 1. DT 24-JAN-2024, entry version 155. DE RecName: Full=Glutaredoxin-2, mitochondrial; DE Flags: Precursor; GN Name=Glrx2; Synonyms=Grx2; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ALTERNATIVE SPLICING (ISOFORMS 1 RP AND 2), FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBCELLULAR LOCATION. RX PubMed=11397793; DOI=10.1074/jbc.m100020200; RA Gladyshev V.N., Liu A., Novoselov S.V., Krysan K., Sun Q.-A., Kryukov V.M., RA Kryukov G.V., Lou M.F.; RT "Identification and characterization of a new mammalian glutaredoxin RT (thioltransferase), Grx2."; RL J. Biol. Chem. 276:30374-30380(2001). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). RC STRAIN=CFW; TISSUE=Lens; RA Reddy P.G., Bhuyan D.K., Bhuyan K.C.; RL Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC STRAIN=C57BL/6J; TISSUE=Testis; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [4] RP TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE. RX PubMed=12954614; DOI=10.1074/jbc.m307866200; RA Jurado J., Prieto-Alamo M.-J., Madrid-Risquez J., Pueyo C.; RT "Absolute gene expression patterns of thioredoxin and glutaredoxin redox RT systems in mouse."; RL J. Biol. Chem. 278:45546-45554(2003). RN [5] RP FUNCTION. RX PubMed=15347644; DOI=10.1074/jbc.m408011200; RA Beer S.M., Taylor E.R., Brown S.E., Dahm C.C., Costa N.J., Runswick M.J., RA Murphy M.P.; RT "Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of RT mitochondrial membrane thiol proteins: implications for mitochondrial redox RT regulation and antioxidant defense."; RL J. Biol. Chem. 279:47939-47951(2004). RN [6] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain, Brown adipose tissue, Heart, and Kidney; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). CC -!- FUNCTION: Glutathione-dependent oxidoreductase that facilitates the CC maintenance of mitochondrial redox homeostasis upon induction of CC apoptosis by oxidative stress. Involved in response to hydrogen CC peroxide and regulation of apoptosis caused by oxidative stress. Acts CC as a very efficient catalyst of monothiol reactions because of its high CC affinity for protein glutathione-mixed disulfides. Can receive CC electrons not only from glutathione (GSH), but also from thioredoxin CC reductase supporting both monothiol and dithiol reactions. Efficiently CC catalyzes both glutathionylation and deglutathionylation of CC mitochondrial complex I, which in turn regulates the superoxide CC production by the complex. Overexpression decreases the susceptibility CC to apoptosis and prevents loss of cardiolipin and cytochrome c release. CC {ECO:0000269|PubMed:11397793, ECO:0000269|PubMed:15347644}. CC -!- ACTIVITY REGULATION: The 2Fe-2S present in the homodimer leads to CC inactivation of the enzyme. The 2Fe-2S may serve as a redox sensor: the CC presence of one-electron oxidants or reductants leading to the loss of CC the 2Fe-2S cluster, subsequent monomerization and activation of the CC enzyme (By similarity). {ECO:0000250}. CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=1.68 mM for HEDS {ECO:0000269|PubMed:11397793}; CC KM=1.77 mM for S-sulfocysteine {ECO:0000269|PubMed:11397793}; CC KM=0.3 mM for L-cystine {ECO:0000269|PubMed:11397793}; CC -!- SUBUNIT: Monomer; active form. Homodimer; inactive form. The homodimer CC is probably linked by 1 2Fe-2S cluster (By similarity). {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: [Isoform 1]: Mitochondrion. CC -!- SUBCELLULAR LOCATION: [Isoform 2]: Nucleus. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; Synonyms=Grx2a; CC IsoId=Q923X4-1; Sequence=Displayed; CC Name=2; CC IsoId=Q923X4-2; Sequence=VSP_015222; CC -!- TISSUE SPECIFICITY: Widely expressed. Highly expressed in testis, and CC at much lower level in kidney and brain. {ECO:0000269|PubMed:12954614}. CC -!- DEVELOPMENTAL STAGE: During development, it is expressed at highest CC level at 11 dpc. {ECO:0000269|PubMed:12954614}. CC -!- SIMILARITY: Belongs to the glutaredoxin family. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAF86465.1; Type=Frameshift; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF380337; AAK85319.1; -; mRNA. DR EMBL; AF276918; AAF86465.1; ALT_FRAME; mRNA. DR EMBL; AK005853; BAB24276.1; -; mRNA. DR CCDS; CCDS15343.1; -. [Q923X4-1] DR CCDS; CCDS15344.1; -. [Q923X4-2] DR RefSeq; NP_001033681.1; NM_001038592.1. [Q923X4-1] DR RefSeq; NP_001033682.1; NM_001038593.1. [Q923X4-2] DR RefSeq; NP_001033683.1; NM_001038594.1. [Q923X4-2] DR RefSeq; NP_075994.2; NM_023505.2. [Q923X4-2] DR RefSeq; XP_006529919.1; XM_006529856.2. [Q923X4-2] DR AlphaFoldDB; Q923X4; -. DR SMR; Q923X4; -. DR BioGRID; 213390; 15. DR STRING; 10090.ENSMUSP00000141022; -. DR iPTMnet; Q923X4; -. DR PhosphoSitePlus; Q923X4; -. DR SwissPalm; Q923X4; -. DR EPD; Q923X4; -. DR MaxQB; Q923X4; -. DR PaxDb; 10090-ENSMUSP00000141022; -. DR ProteomicsDB; 266818; -. [Q923X4-1] DR ProteomicsDB; 266819; -. [Q923X4-2] DR Pumba; Q923X4; -. DR DNASU; 69367; -. DR Ensembl; ENSMUST00000111957.10; ENSMUSP00000107588.4; ENSMUSG00000018196.19. [Q923X4-2] DR Ensembl; ENSMUST00000129653.3; ENSMUSP00000121010.2; ENSMUSG00000018196.19. [Q923X4-2] DR Ensembl; ENSMUST00000145969.8; ENSMUSP00000121665.2; ENSMUSG00000018196.19. [Q923X4-2] DR Ensembl; ENSMUST00000185362.7; ENSMUSP00000141022.2; ENSMUSG00000018196.19. [Q923X4-1] DR GeneID; 69367; -. DR KEGG; mmu:69367; -. DR UCSC; uc007cwz.1; mouse. [Q923X4-1] DR AGR; MGI:1916617; -. DR CTD; 51022; -. DR MGI; MGI:1916617; Glrx2. DR VEuPathDB; HostDB:ENSMUSG00000018196; -. DR eggNOG; KOG1752; Eukaryota. DR GeneTree; ENSGT00940000167705; -. DR HOGENOM; CLU_026126_7_2_1; -. DR InParanoid; Q923X4; -. DR OMA; INGNCVG; -. DR OrthoDB; 203654at2759; -. DR PhylomeDB; Q923X4; -. DR TreeFam; TF319627; -. DR BioGRID-ORCS; 69367; 1 hit in 78 CRISPR screens. DR ChiTaRS; Glrx2; mouse. DR PRO; PR:Q923X4; -. DR Proteomes; UP000000589; Chromosome 1. DR RNAct; Q923X4; Protein. DR Bgee; ENSMUSG00000018196; Expressed in ventricular zone and 257 other cell types or tissues. DR ExpressionAtlas; Q923X4; baseline and differential. DR GO; GO:0030425; C:dendrite; ISO:MGI. DR GO; GO:0043231; C:intracellular membrane-bounded organelle; ISO:MGI. DR GO; GO:0005759; C:mitochondrial matrix; ISO:MGI. DR GO; GO:0005739; C:mitochondrion; HDA:MGI. DR GO; GO:0043025; C:neuronal cell body; ISO:MGI. DR GO; GO:0005654; C:nucleoplasm; ISO:MGI. DR GO; GO:0005634; C:nucleus; ISS:UniProtKB. DR GO; GO:0051537; F:2 iron, 2 sulfur cluster binding; IEA:UniProtKB-KW. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0015035; F:protein-disulfide reductase activity; IDA:MGI. DR GO; GO:0042542; P:response to hydrogen peroxide; ISS:UniProtKB. DR GO; GO:0010033; P:response to organic substance; ISS:UniProtKB. DR CDD; cd03419; GRX_GRXh_1_2_like; 1. DR Gene3D; 3.40.30.10; Glutaredoxin; 1. DR InterPro; IPR002109; Glutaredoxin. DR InterPro; IPR011899; Glutaredoxin_euk/vir. DR InterPro; IPR014025; Glutaredoxin_subgr. DR InterPro; IPR036249; Thioredoxin-like_sf. DR NCBIfam; TIGR02180; GRX_euk; 1. DR PANTHER; PTHR46679; -; 1. DR PANTHER; PTHR46679:SF1; GLUTAREDOXIN-2, MITOCHONDRIAL; 1. DR Pfam; PF00462; Glutaredoxin; 1. DR PRINTS; PR00160; GLUTAREDOXIN. DR SUPFAM; SSF52833; Thioredoxin-like; 1. DR PROSITE; PS51354; GLUTAREDOXIN_2; 1. DR Genevisible; Q923X4; MM. PE 1: Evidence at protein level; KW 2Fe-2S; Alternative splicing; Disulfide bond; Electron transport; KW Glutathionylation; Iron; Iron-sulfur; Metal-binding; Mitochondrion; KW Nucleus; Redox-active center; Reference proteome; Transit peptide; KW Transport. FT TRANSIT 1..19 FT /note="Mitochondrion" FT /evidence="ECO:0000255" FT CHAIN 20..156 FT /note="Glutaredoxin-2, mitochondrial" FT /id="PRO_0000011629" FT DOMAIN 50..150 FT /note="Glutaredoxin" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00686" FT BINDING 61 FT /ligand="[2Fe-2S] cluster" FT /ligand_id="ChEBI:CHEBI:190135" FT /ligand_note="ligand shared between dimeric partners" FT /note="in inactive form" FT /evidence="ECO:0000250" FT BINDING 67 FT /ligand="glutathione" FT /ligand_id="ChEBI:CHEBI:57925" FT /evidence="ECO:0000250" FT BINDING 102 FT /ligand="glutathione" FT /ligand_id="ChEBI:CHEBI:57925" FT /evidence="ECO:0000250" FT BINDING 114 FT /ligand="glutathione" FT /ligand_id="ChEBI:CHEBI:57925" FT /evidence="ECO:0000250" FT BINDING 146 FT /ligand="[2Fe-2S] cluster" FT /ligand_id="ChEBI:CHEBI:190135" FT /ligand_note="ligand shared between dimeric partners" FT /note="in inactive form" FT /evidence="ECO:0000250" FT MOD_RES 70 FT /note="S-glutathionyl cysteine; alternate" FT /evidence="ECO:0000250" FT DISULFID 70..73 FT /note="Redox-active; alternate" FT /evidence="ECO:0000250" FT VAR_SEQ 1..33 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:16141072, ECO:0000303|Ref.2" FT /id="VSP_015222" SQ SEQUENCE 156 AA; 17307 MW; 605BA5C62A139C3E CRC64; MSWRRAASVG RRLVASGRIL AGRRGAAGAA GSGMGNSTSS FWGKSTTTPV NQIQETISNN CVVIFSKTSC SYCSMAKKIF HDMNVNYKAV ELDMLEYGNQ FQDALHKMTG ERTVPRIFVN GRFIGGAADT HRLHKEGKLL PLVHQCYLKK KQEERH //